Business Daily Media

Business Marketing

.

Hua Medicine Announces Acceptance of a New Drug Application for Dorzagliatin in China - First Glucokinase Activator (GKA) Globally

  • Written by ACN Newswire - Press Releases

Hua Medicine Announces Acceptance of a New Drug Application for Dorzagliatin in China - First Glucokinase Activator (GKA) Globally

SHANGHAI, CHINA, Apr 23, 2021 - (ACN Newswire) - Hua Medicine (the "Company", Stock Code: 2552.HK), today announced that the New Drug Application (NDA) for dorzagliatin for the treatment of Type 2 Diabetes (T2D) was accepted by the China National Medical Products Administration (NMPA). Dorzagliatin is the first glucokinase activator (GKA) to...

Popular

ARTESIAN LAUNCHES THE ARTESIAN GREEN & SUSTAINABLE BOND FUND

Australian based fund manager, Artesian Capital Management (Artesian) has launched Australia’s first corporate focused, green and sustainable bond fund open to wholesale and retail investors. Seeded by an Australian ethically ...

How to Deal With An HMRC Enquiry?

If you get that morning call or letter from the HMRC that they would like to investigate your tax position, you will most likely panic. You will not know what awaits you if this is your first time facing a tax investigation by H...

Automation is here, and it’s revolutionising how we work

It’s no secret that digital transformation initiatives have dramatically accelerated during the worst of the COVID-19 pandemic. Business leaders raced to buy new technology to transition to a work from home model. As the econo...

Virtual Office
Tomorrow Business Growth